.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
Cantor Fitzgerald
AstraZeneca
McKesson
Argus Health
Fish and Richardson
Julphar
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

WELLCOVORIN Drug Profile

« Back to Dashboard

What is the patent landscape for Wellcovorin, and when can generic versions of Wellcovorin launch?

Wellcovorin is a drug marketed by Glaxosmithkline and is included in five NDAs.

The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.

Summary for Tradename: WELLCOVORIN

Patents:0
Applicants:1
NDAs:5
Bulk Api Vendors: see list41
Clinical Trials: see list18
Patent Applications: see list6,773
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:WELLCOVORIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
WELLCOVORIN
leucovorin calcium
INJECTABLE;INJECTION089833-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
WELLCOVORIN
leucovorin calcium
TABLET;ORAL018342-001Jul 8, 1983DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
WELLCOVORIN
leucovorin calcium
INJECTABLE;INJECTION089834-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
WELLCOVORIN
leucovorin calcium
INJECTABLE;INJECTION087439-001Oct 19, 1982DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
WELLCOVORIN
leucovorin calcium
INJECTABLE;INJECTION089465-001Jan 23, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Baxter
Cipla
UBS
McKinsey
Cantor Fitzgerald
Fish and Richardson
Covington
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot